Reproduction in mammals is controlled by interactions between the hypothalamus, anterior pituitary, and gonads. The hypothalamus secretes synchronized pulses of gonadotropin-releasing hormone (GnRH) as the central initiator of the reproductive hormonal cascade from the diffusely arranged network of neuronal nerve endings of about 800 (rodents) to 1,500–2,000 (human) into the hypophyseal portal system every 30–120 min. GnRH stimulates the biosynthesis and secretion of the gonadotropic hormones, LH, and FSH by the anterior pituitary that in turn regulate the production of gametes and gonadal hormones as a key regulator of the reproductive functions. In the 1970 s, GnRH was first isolated from hypothalamus of pigs and sheep, and the subsequent realization that the decapeptide sequence was conserved across all mammals. This form of GnRH is referred as GnRH-I or type I mammalian GnRH (mGnRH). In 1977, Andrew Schally, Roger Guillemin, and co-workers shared the Nobel Prize in the field of Medicine for their discovery. In the early 1980 s, a second GnRH isoform from chickens was isolated (chicken GnRH; GnRH-II) [1] and a third isoform was identified in fish (salmon GnRH) [2]. Currently, a total of 23 different isoforms of chordate GnRH have been isolated [3–5]. All of these isoforms are decapeptides that share a high degree of sequence identity at both NH2- and COOH-terminals. This overview describes the recent literature regarding the GnRH primary structure, tissue distribution in female reproductive system, synthesis, secretion, and signaling pathways with current understanding on their cognate receptors and functional significance in relation to female reproductive system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Miyamoto K, Hasegawa Y, Nomura M, et al. Identification of a second gonadotropin releasing hormone in chicken hypothalamus: evidence that gonadotropin secretion is probably controlled by two distinct gonadotropin-releasing hormones in avian species. Proc Natl Acad Sci USA 1984; 81:3874–8.
Sherwood NM, Harvey B, Brownstein MJ, et al. Gonadotropin-releasing hormone (Gn-RH) in striped mullet (Mugil cephalus), milkfish (Chanos chanos), and rainbow trout (Salmo gairdneri): comparison with salmon GnRH. Gen Comp Endocrinol 1984; 55:174–81.
Guilgur LG, Moncaut NP, Canário AV, et al. Evolution of GnRH ligands and receptors in gnathostomata. Comp Biochem Physiol A Mol Integr Physiol 2006; 144:272–83.
Morgan K, Millar RP. Evolution of GnRH ligand precursors and GnRH receptors in protochordate and vertebrate species. Gen Comp Endocrinol 2004; 139:191–7.
Kah O, Lethimonier C, Somoza G, et al. GnRH and GnRH receptors in metazoa: a historical, comparative, and evolutive perspective. Gen Comp Endocrinol 2007; 153:346–64.
Seeburg PH, Adelman JP. Characterization of cDNA for precursor of human luteinizing hormone releasing hormone. Nature 1984; 311:666–8.
Millar RP. GnRHs and GnRH receptors. Anim Reprod Sci 2005; 88:5–28.
Rispoli LA, Nett TM. Pituitary gonadotropin-releasing hormone (GnRH) receptor: structure, distribution and regulation of expression. Anim Reprod Sci 2005; 88:57–74.
Choi JH, Gilks CB, Auersperg N, et al. Immunolocalization of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and type I GnRH receptor during follicular development in the human ovary. J Clin Endocrinol Metab 2006; 91:4562–70.
Choi JH, Choi KC, Auersperg N, et al. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells. Endocrinol Relat Cancer 2006; 13:641–51.
Cheng CK, Leung PC. Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans. Endocr Rev 2005; 26:283–306.
Chakrabarti N, Subbarao T, Sengupta A, et al. Expression of mRNA and proteins for GnRH I and II and their receptors in primate corpus luteum during menstrual cycle. Mol Reprod Dev 2008; 75:1567–1577.
Leung PC, Cheng CK, Zhu XM. Multi-factorial role of GnRH-I and GnRH-II in the human ovary. Mol Cell Endocrinol 2003; 202:145–53.
Metallinou C, Asimakopoulos B, Schröer A, et al. Gonadotropin-releasing hormone in the ovary. Reprod Sci 2007; 14:737–49.
Ramakrishnappa N, Rajamahendran R, Lin YM, et al. GnRH in non-hypothalamic reproductive tissues. Anim Reprod Sci 2005; 88:95–113.
Sengupta A, Baker T, Chakrabarti N, et al. Localization of immunoreactive gonadotropin-releasing hormone and relative expression of its mRNA in the oviduct during pregnancy in rats. J Histochem Cytochem 2007; 55:525–34.
Sengupta A, Chakrabarti N, Sridaran R. Presence of immunoreactive gonadotropin releasing hormone (GnRH) and its receptor (GnRHR) in rat ovary during pregnancy. Mol Reprod Dev 2008; 75:1031–44.
Clarke IJ, Pompolo S. Synthesis and secretion of GnRH. Animal Reprod Sci 2005; 88:29–55.
Yang-Feng TL, Seeburg PH, Francke U. Human luteinizing hormone-releasing hormone gene (LHRH) is located on short arm of chromosome 8 (region 8p11.2----p21). Somat Cell Mol Genet 1986; 12:95–100.
Schirman-Hildesheim TD, Bar T, Ben-Aroya N, et al. Differential gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acid expression patterns in different tissues of the female rat across the estrous cycle. Endocrinology 2005; 146:3401–8.
Hapgood JP, Sadie H, van Biljon W, et al. Regulation of expression of mammalian gonadotrophin-releasing hormone receptor genes. J Neuroendocrinol 2005; 17:619–38.
Millar RP, Lu ZL, Pawson AJ, et al. Gonadotropin-releasing hormone receptors. Endocr Rev 2004; 25:235–75.
Faurholm B, Millar RP, Katz AA. The genes encoding the type II gonadotropin-releasing hormone receptor and the ribonucleoprotein RBM8A in humans overlap in two genomic loci. Genomics 2001; 78:15–8.
Sengupta A, Sridaran R. Expression and localization of gonadotropin-releasing hormone receptor in the rat oviduct during pregnancy. J Histochem Cytochem 2008; 56:25–31.
Ruf F, Fink MY, Sealfon SC. Structure of the GnRH receptor-stimulated signaling network: insights from genomics. Front Neuroendocrinol 2003; 24:181–99.
Caunt CJ, Finch AR, Sedgley KR, et al. GnRH receptor signalling to ERK: kinetics and compartmentalization. Trends Endocrinol Metab 2006; 17:308–13.
Motola S, Cao X, Ashkenazi H, et al. GnRH actions on rat preovulatory follicles are mediated by paracrine EGF-like factors. Mol Reprod Dev 2006; 73:1271–6.
Pawson AJ, McNeilly AS. The pituitary effects of GnRH. Anim Reprod Sci 2005; 88:75–94.
Chen A, Laskar-Levy O, Ben-Aroya N, et al. Transcriptional regulation of the human GnRH II gene is mediated by a putative cAMP response element. Endocrinology 2001; 142: 3483–92.
Chen A, Ziv K, Laskar-Levy O, et al. The transcription of the hGnRH-I and hGnRH-II genes in human neuronal cells is differentially regulated by estrogen. J Mol Neurosci 2002; 18:67–76.
Stocco C, Telleria C, Gibori G. The molecular control of corpus luteum formation, function, and regression. Endocr Rev 2007; 28:117–49.
Lareu RR, Lacher MD, Bradley CK, et al. Regulated expression of inhibitor of apoptosis protein 3 in the rat corpus luteum. Biol Reprod 2003; 68:2232–40.
Papadopoulos V, Dharmarajan AM, Li H, et al. Mitochondrial peripheral-type benzodiazepine receptor expression. Correlation with gonadotropin-releasing hormone (GnRH) agonist-induced apoptosis in the corpus luteum. Biochem Pharmacol 1999; 58:1389–93.
Sridaran R, Hisheh S, Dharmarajan AM. Induction of apoptosis by a gonadotropin-releasing hormone agonist during early pregnancy in the rat. Apoptosis 1998; 3:51–7.
Sridaran R, Philip GH, Li H, et al. GnRH agonist treatment decreases progesterone synthesis, luteal peripheral benzodiazepine receptor mRNA, ligand binding and steroidogenic acute regulatory protein expression during pregnancy. J Mol Endocrinol 1999; 22:45–54.
Sridaran R, Lee MA, Haynes L, et al. GnRH action on luteal steroidogenesis during pregnancy. Steroids 1999; 64: 618–23.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
- AP-1:
-
activator protein-1
- Bcl-2:
-
proto-oncogene
- Bfl-1/A1:
-
Bcl-2 family member
- Caov-3:
-
ovarian cell line
- C/EBP:
-
CCAAT/enhancer binding protein
- c-Fos:
-
product of the proto-oncogene c-fos that dimerize with c-Jun (c-Fos/c-Jun heterodimer) to form the transcription factor AP-1
- c-IAP1:
-
caspase inhibitor
- c-IAP2:
-
caspase inhibitor
- c-Jun:
-
product of the proto-oncogene c-jun that dimerize with c-Fos to form the transcription factor AP-1.
- CRE:
-
cAMP response element
- DAG:
-
diacylglycerol
- dbB:
-
diagonal band of Broca
- EFO-21:
-
ovarian cancer cell line
- EFO-27:
-
ovarian cancer cell line
- EGF:
-
epidermal growth factor
- EGFR:
-
epidermal growth factor receptor
- EL:
-
extracellular loop
- ER:
-
estrogen receptor
- ERK:
-
extracellular signal-regulated kinase
- FSH:
-
follicle stimulating hormone
- GAP:
-
GnRH-associated peptide region
- GGH3:
-
somatolactotroph cells
- GLCs:
-
granulosa luteal cells
- GnRH:
-
gonadotropin-releasing hormone
- GnRHR:
-
gonadotropin-releasing hormone receptor
- GnSE:
-
GnRHR-specific enhancer
- GPCR:
-
G protein-coupled receptors
- GRAS:
-
GnRHR activating sequence
- GRE/PRE:
-
glucocorticoid responsive element/ progesterone responsive element
- GRKs:
-
G protein-coupled receptor kinases
- hGL:
-
human granulosa-luteal cells
- HPLC:
-
high-performance liquid chromatography
- IEVT:
-
immortalized extravillous trophoblast
- IkB:
-
inhibitor of kappa B
- IL:
-
intracellular loop
- IVF:
-
in vitro fertilization
- JEG-3:
-
placental cell line
- JNK:
-
Jun N-terminal kinase
- LbT2:
-
gonadotroph cell line
- LH:
-
luteinizing hormone
- MAPK:
-
mitogen activated protein kinases
- MEK 1:
-
threonine and tyrosine recognition kinase
- MMP:
-
matrix metalloproteinase
- MT1-R:
-
melatonin receptor subtype
- MT2-R:
-
melatonin receptor subtype
- NF-kB:
-
nuclear factor-kappa B
- NRE:
-
negative regulatory element
- OE:
-
ovarian epithelial cells
- OSE:
-
ovarian surface epithelial cells
- OVCAR-3:
-
ovarian cell line
- PAI-I:
-
plasminogen activator inhibitor
- PCR:
-
polymerase chain reaction
- Pitx-1:
-
pan pituitary homeobox transcription factor
- PKC:
-
protein kinase C
- POA:
-
preoptic area of the brain
- POA-AH:
-
preoptic area of anterior hypothalamus
- PR:
-
progesterone receptor
- PRE:
-
progesterone receptor elements
- Ras:
-
oncogene of the Harvey (rasH) and Kristen (rasK) rat sarcoma viruses. These genes, which are frequently activated in human tumors, encode a 21 kD G-protein.
- RBM-8A:
-
RNA-binding motif protein-8A
- RT-PCR:
-
reverse transcriptase polymerase chain reaction
- SF-1:
-
steroidogenic factor-1
- SK-OV-3:
-
ovarian cell line
- Src:
-
name of the first described retroviral oncogene (v-src), from the chicken Rous sarcoma retrovirus and its precursor (c-src), which encode a membrane-associated protein kinase.
- SURG-1:
-
sequence underlying responsiveness to GnRH element
- SVOG-4m:
-
human ovarian granulosa-luteal cell line
- TLCs:
-
theca luteal cells
- SVOG-4o:
-
human ovarian granulosa-luteal cell line
- TE-671:
-
neuronal cell line
- TM:
-
trans-membrane
- UTR:
-
untranslated region
- IP3:
-
inositol 1,4,5-triphosphate
- αT3-1:
-
ovarian cell line
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Chowdhury, I., Sridaran, R. (2009). GnRH-GnRH-Receptor System in the Mammalian Female Reproductive Tract. In: Chedrese, P. (eds) Reproductive Endocrinology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-88186-7_13
Download citation
DOI: https://doi.org/10.1007/978-0-387-88186-7_13
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-88185-0
Online ISBN: 978-0-387-88186-7
eBook Packages: MedicineMedicine (R0)